Subgroup analysis by HER2 expression from phase 1/2 trial of patients with HER3 expressing metastatic breast cancer highlighted in a second Presidential Session
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
A funding to expand operations and provide better patient care
Proposed combination enhances Pfizer’s position as a leading company in oncology
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
Subscribe To Our Newsletter & Stay Updated
